Jin Medical International Ltd.
ZJYL
$0.6407
-$0.0019-0.30%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.47M | 6.47M | 5.28M | 5.28M | 4.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.47M | 6.47M | 5.28M | 5.28M | 4.78M |
| Cost of Revenue | 3.57M | 3.57M | 3.38M | 3.38M | 3.12M |
| Gross Profit | 2.91M | 2.91M | 1.90M | 1.90M | 1.67M |
| SG&A Expenses | 1.23M | 1.23M | 948.70K | 948.70K | 623.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 23.10K | 23.10K | 30.50K | 30.50K | 39.10K |
| Total Operating Expenses | 5.27M | 5.27M | 4.66M | 4.66M | 4.24M |
| Operating Income | 1.20M | 1.20M | 614.60K | 614.60K | 547.90K |
| Income Before Tax | 1.09M | 1.09M | 1.01M | 1.01M | 625.80K |
| Income Tax Expenses | 227.40K | 227.40K | 154.50K | 154.50K | 69.80K |
| Earnings from Continuing Operations | 857.70K | 857.70K | 852.20K | 852.20K | 555.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 83.20K | 83.20K | 44.90K | 44.90K | -- |
| Net Income | 940.90K | 940.90K | 897.00K | 897.00K | 555.90K |
| EBIT | 1.20M | 1.20M | 614.60K | 614.60K | 547.90K |
| EBITDA | 1.26M | 1.26M | 674.60K | 674.60K | 603.60K |
| EPS Basic | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 156.55M | 156.55M | 156.40M | 156.40M | 155.05M |
| Average Diluted Shares Outstanding | 156.55M | 156.55M | 156.40M | 156.40M | 155.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |